What Hath GSK Wrought? More Compliance Lessons From China

Published date20 December 2013
Law FirmThomas Fox
Subject MatterBribery,China,Compliance,Corruption,Generic Drugs,GlaxoSmithKline,Medical Devices,Pharmaceutical Industry,Prescription Drugs

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT